Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9,10-dehydro-19-nortestosterone
2. Zx4vv1akuf
3. Chembl2311179
4. Ru-3118
5. 17-hydroxy-13-methyl-2,6,7,8,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-one
6. (8s,13s,14s,17s)-17-hydroxy-13-methyl-2,6,7,8,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-one
7. (10s,11s,14s)-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-5-one
8. Nordienolone
9. Unii-zx4vv1akuf
10. Schembl3867182
11. Dtxsid80471835
12. 3-oxo-4,9-estradien-17beta-ol
13. 4,9-estradien-17beta-ol-3-one
14. Zinc4026402
15. Bdbm50422635
16. Estra-4,9-diene-17beta-ol-3-one
17. 17-
18. A-hydroxyestra-4,9-dien-3-one
19. 17 Beta-hydroxy-4,9-estradien-3-one
20. (17beta)-17-hydroxyestra-4,9-dien-3-one
21. 17beta-hydroxy-estra-4,9(10)-dien-3-one
22. 3-oxo-4,9-estradien-17.beta.-ol
23. 4,9-estradien-17.beta.-ol-3-one
24. Cs-0212818
25. D4162
26. Ec 612-953-5
27. Estra-4,9-diene-17.beta.-ol-3-one
28. 17.beta.-hydroxyestra-4,9-dien-3-one
29. Estra-4,9-dien-3-one, 17-hydroxy-, (17beta)-
30. Q27295932
31. (17.beta.)-17-hydroxyestra-4,9-dien-3-one
32. Estra-4,9-dien-3-one, 17-hydroxy-, (17.beta.)-
| Molecular Weight | 272.4 g/mol |
|---|---|
| Molecular Formula | C18H24O2 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 272.177630004 g/mol |
| Monoisotopic Mass | 272.177630004 g/mol |
| Topological Polar Surface Area | 37.3 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 528 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
61
PharmaCompass offers a list of 9(10)-Dehydronandrolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 9(10)-Dehydronandrolone manufacturer or 9(10)-Dehydronandrolone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 9(10)-Dehydronandrolone manufacturer or 9(10)-Dehydronandrolone supplier.
PharmaCompass also assists you with knowing the 9(10)-Dehydronandrolone API Price utilized in the formulation of products. 9(10)-Dehydronandrolone API Price is not always fixed or binding as the 9(10)-Dehydronandrolone Price is obtained through a variety of data sources. The 9(10)-Dehydronandrolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 9(10)-Dehydronandrolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 9(10)-Dehydronandrolone, including repackagers and relabelers. The FDA regulates 9(10)-Dehydronandrolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 9(10)-Dehydronandrolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 9(10)-Dehydronandrolone supplier is an individual or a company that provides 9(10)-Dehydronandrolone active pharmaceutical ingredient (API) or 9(10)-Dehydronandrolone finished formulations upon request. The 9(10)-Dehydronandrolone suppliers may include 9(10)-Dehydronandrolone API manufacturers, exporters, distributors and traders.
9(10)-Dehydronandrolone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 9(10)-Dehydronandrolone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 9(10)-Dehydronandrolone GMP manufacturer or 9(10)-Dehydronandrolone GMP API supplier for your needs.
A 9(10)-Dehydronandrolone CoA (Certificate of Analysis) is a formal document that attests to 9(10)-Dehydronandrolone's compliance with 9(10)-Dehydronandrolone specifications and serves as a tool for batch-level quality control.
9(10)-Dehydronandrolone CoA mostly includes findings from lab analyses of a specific batch. For each 9(10)-Dehydronandrolone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
9(10)-Dehydronandrolone may be tested according to a variety of international standards, such as European Pharmacopoeia (9(10)-Dehydronandrolone EP), 9(10)-Dehydronandrolone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (9(10)-Dehydronandrolone USP).
